J
James I. Meek
Researcher at Yale University
Publications - 64
Citations - 4583
James I. Meek is an academic researcher from Yale University. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 20, co-authored 39 publications receiving 3602 citations.
Papers
More filters
Journal ArticleDOI
Emerging Infections Program— State Health Department Perspective
James L. Hadler,Richard Danila,Paul R. Cieslak,James I. Meek,William Schaffner,Kirk E. Smith,Matthew L. Cartter,Lee H. Harrison,Duc J. Vugia,Ruth Lynfield +9 more
TL;DR: This network has enriched research and workforce training and produced a synergy between state and federal levels.
Journal ArticleDOI
Unexplained deaths in Connecticut, 2002-2003: failure to consider category a bioterrorism agents in differential diagnoses.
John P. Palumbo,James I. Meek,Darcy M. Fazio,Susan B. Turner,James L. Hadler,Andre N. Sofair +5 more
TL;DR: Few unexplained deaths in Connecticut could possibly be the result of the bioterrorism agents studied, except for anthrax, and more effective clinician education and surveillance strategies are needed to minimize the potential to miss initial cases in a biOTerrorism attack.
Journal ArticleDOI
Rates of Severe Influenza-Associated Outcomes Among Older Adults Living With Diabetes-Influenza Hospitalization Surveillance Network (FluSurv-NET), 2012-2017.
Daniel Owusu,Melissa A. Rolfes,Carmen Sofia Arriola,Pam Daily Kirley,Nisha B Alden,James I. Meek,Evan J. Anderson,Maya Monroe,Sue Kim,Ruth Lynfield,Kathy Angeles,Nancy L Spina,Christina B Felsen,Laurie M Billing,Ann Thomas,H. Keipp Talbot,William Schaffner,Ryan Chatelain,Carrie Reed,Shikha Garg +19 more
TL;DR: Older adults with DM have higher rates of severe influenza-associated outcomes compared to those without DM, reinforcing the importance of preventing influenza virus infections through annual vaccination, and early treatment of influenza illness with antivirals in older adults withDM.
Journal ArticleDOI
Hospital-acquired influenza in the United States, FluSurv-NET, 2011-2012 through 2018-2019.
Charisse N Cummings,Alissa O’Halloran,Tali Azenkot,Arthur Reingold,Nisha B Alden,James I. Meek,Evan J. Anderson,Evan J. Anderson,Patricia Ryan,Sue Kim,Melissa McMahon,Chelsea McMullen,Nancy L Spina,Nancy M. Bennett,Laurie M Billing,Ann Thomas,William Schaffner,H. Keipp Talbot,Andrea George,Carrie Reed,Shikha Garg +20 more
TL;DR: The overall adjusted rate of hospital-acquired (HA) influenza was 0.4 per 100,000 persons in the US during 2011-2012 through 2018-2019 seasons.
Journal ArticleDOI
Characteristics and treatment of hospitalized pregnant women with COVID-19
Ahlia Sekkarie,Rebecca A. Woodruff,Michael Whitaker,Michael R. Kramer,Lauren B. Zapata,Sascha R. Ellington,Dana Meaney-Delman,Huong Pham,Kadam Patel,Christopher Taylor,Shua J Chai,Breanna Kawasaki,James I. Meek,Kyle P Openo,Andy Weigel,Lauren Leegwater,Kathryn Como-Sabetti,S. L. Ropp,Alison Muse,Nancy M. Bennett,Laurie M Billing,Melissa Sutton,H. Keipp Talbot,Mary Hill,Fiona Havers +24 more
TL;DR: In this article , the authors describe the vaccination status, treatment, and outcomes of hospitalized, symptomatic pregnant women with COVID-19 and estimate whether treatment differs by pregnancy status among treatment-eligible (i.e., requiring supplemental oxygen per National Institutes of Health guidelines at the time of the study) women.